Evidence map›Paper›PMID 17931959›Full record

ArticleMutation research2008

The role of polycyclic aromatic hydrocarbon-DNA adducts in inducing mutations in mouse skin.

Dhrubajyoti Chakravarti, Divya Venugopal, Paula C Mailander, Jane L Meza, Sheila Higginbotham, Ercole L Cavalieri, Eleanor G Rogan

Open access · greenAbstract read
In one paragraph

Article in Mutation research, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Review
  3. Relative genotoxicity of polycyclic aromatic hydrocarbons inferred from free energy perturbation approaches.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  4. Nutrients · 2024
    Article
  5. Article
  6. Benzo[International journal of molecular sciences · 2022
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Metabolically competent human skin models: activation and genotoxicity of benzo[a]pyrene.Toxicological sciences : an official journal of the Society of Toxicology · 2013
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Dhrubajyoti ChakravartiEppley Institute for Research in Cancer and Allied Diseases, Omaha, NE 68198-6805, USA. dchakrav@unmc.edu
Divya Venugopal
Paula C Mailander
Jane L Meza
Sheila Higginbotham
Ercole L Cavalieri
Eleanor G Rogan
Nebraska Medical Center · USUniversity of Nebraska Medical Center · US

Funding

UNMC/EPPLEY CANCER CENTER SUPPORT GRANTP30CA036727 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI Apar Kishor Ganti · 1985 to 2026
$55.0M
THE REDOX-MEDIATED REGULATION OF IRON-RESPONSIVE GENE EXPRESSION IN LIVERP20RR017675 · NCRR · UNIVERSITY OF NEBRASKA LINCOLN · PI GRASS, GREGOR · 2002 to 2011
$20.4M
UNIFYING INITIATION MECHANISM OF BREAST/PROSTATE CANCERP01CA049210 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI CAVALIERI, ERCOLE L · 1989 to 2004
$3.3M
NCI NIH HHS CA 36727NCI NIH HHS P01 CA049210NCI NIH HHS P01 CA 49210NCI NIH HHS P30 CA036727NCRR NIH HHS P20 RR017675NCRR NIH HHS P20 RR 17675
6 · The paper itself

Abstract

Polycyclic aromatic hydrocarbons (PAH) form stable and depurinating DNA adducts in mouse skin to induce preneoplastic mutations. Some mutations transform cells, which then clonally expand to establish tumors. Strong clues about the mutagenic mechanism can be obtained if the PAH-DNA adducts can be correlated with both preneoplastic and tumor mutations. To this end, we studied mutagenesis in PAH-treated early preneoplastic skin (1 day after exposure) and in the induced papillomas in SENCAR mice. Papillomas were studied by PCR amplification of the H-ras gene and sequencing. For benzo[a]pyrene (BP), BP-7,8-dihydrodiol (BPDHD), 7,12-dimethylbenz[a]anthracene (DMBA) and dibenzo[a,l]pyrene (DB[a,l]P), the codon 13 (GGC to GTC) and codon 61 (CAA to CTA) mutations in papillomas corresponded to the relative levels of Gua and Ade-depurinating adducts, despite BP and BPDHD forming significant amounts of stable DNA adducts. Such a relationship was expected for DMBA and DB[a,l]P, as they formed primarily depurinating adducts. These results suggest that depurinating adducts play a major role in forming the tumorigenic mutations. To validate this correlation, preneoplastic skin mutations were studied by cloning H-ras PCR products and sequencing individual clones. DMBA- and DB[a,l]P-treated skin showed primarily A.T to G.C mutations, which correlated with the high ratio of the Ade/Gua-depurinating adducts. Incubation of skin DNA with T.G-DNA glycosylase eliminated most of these A.T to G.C mutations, indicating that they existed as G.T heteroduplexes, as would be expected if they were formed by errors in the repair of abasic sites generated by the depurinating adducts. BP and its metabolites induced mainly G.C to T.A mutations in preneoplastic skin. However, PCR over unrepaired anti-BPDE-N(2)dG adducts can generate similar mutations as artifacts of the study protocol, making it difficult to establish an adduct-mutation correlation for determining which BP-DNA adducts induce the early preneoplastic mutations. In conclusion, this study suggests that depurinating adducts play a major role in PAH mutagenesis.

Indexed as

9,10-Dimethyl-1,2-benzanthraceneAnimalsBase SequenceBenzopyrenesCarcinogensDNA AdductsFemaleGenes, rasMiceMice, Inbred SENCARModels, GeneticMutationPapillomaPolycyclic Aromatic HydrocarbonsPolymerase Chain ReactionSkin9,10-Dimethyl-1,2-benzanthraceneBenzopyrenesCarcinogensDNA AdductsPolycyclic Aromatic Hydrocarbons

Identifiers

PMID17931959
PMCPMC2254211
OpenAlexW1984624556

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.